PRIA Logo™
119-hr-10127119th Congress

TRANS Government Research Act

Sponsored By: Representative Mace, Nancy [R-SC-1]

Introduced

Summary

Bars federal funding for research on gender-related medical treatments. This bill would prohibit the use of federal funds, directly or indirectly, to conduct, support, or fund research that studies the effects of treatments that alter a person’s body or physical appearance so it no longer corresponds to that person’s sex.

Show full summary
  • Researchers and academic institutions would be barred from receiving federal money for studies that evaluate the effects of the listed surgeries, hormone therapies, or puberty blockers used to change body or appearance.
  • People who receive or consider these treatments and their clinicians would see federally funded studies on those interventions restricted, because the ban covers research on the listed procedures and hormonal regimens.
  • Federal grant programs would have a clear scope to enforce because the bill defines "covered research" and gives specific definitions for "female," "male," "sex," and enumerates surgical procedures and hormone treatments included in the prohibition.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

1 provisions identified: 0 benefits, 1 costs, 0 mixed.

Ban on federal funding for gender research

This bill would prohibit Federal funds from being used to directly or indirectly conduct, support, or fund research that studies the effects of gender-related medical treatment or any means of altering a person’s body or appearance so it does not match their sex. It would define "gender-related medical treatment" by listing many specific surgeries, exogenous sex hormones (testosterone or estrogen), and puberty blockers for people described as female or male. It would also define the terms "female," "male," and "sex" by biological reproductive function. The bill text does not include an effective date, spending amounts, or enforcement rules in this section.

Sponsors & CoSponsors

Sponsor

Mace, Nancy [R-SC-1]

SC • R

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation